nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—GRIN2A—CREB phosphorylation through the activation of CaMKII—ACTN2—dilated cardiomyopathy	0.0158	0.0388	CbGpPWpGaD
Memantine—GRIN2A—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0158	0.0388	CbGpPWpGaD
Memantine—SLC22A2—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0147	0.0361	CbGpPWpGaD
Memantine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—ACTN2—dilated cardiomyopathy	0.0145	0.0355	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of CaMKII—ACTN2—dilated cardiomyopathy	0.0138	0.0338	CbGpPWpGaD
Memantine—GRIN1—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0138	0.0338	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of CaMKII—ACTN2—dilated cardiomyopathy	0.0134	0.033	CbGpPWpGaD
Memantine—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0134	0.033	CbGpPWpGaD
Memantine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—ACTN2—dilated cardiomyopathy	0.0126	0.0309	CbGpPWpGaD
Memantine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—ACTN2—dilated cardiomyopathy	0.0123	0.0302	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—ACTN2—dilated cardiomyopathy	0.0103	0.0253	CbGpPWpGaD
Memantine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00996	0.0244	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—ACTN2—dilated cardiomyopathy	0.00899	0.0221	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—ACTN2—dilated cardiomyopathy	0.00876	0.0215	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—ACTN2—dilated cardiomyopathy	0.00848	0.0208	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.00781	0.0192	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—ACTN2—dilated cardiomyopathy	0.0074	0.0182	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—ACTN2—dilated cardiomyopathy	0.00721	0.0177	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.00682	0.0167	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.00664	0.0163	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00455	0.0112	CbGpPWpGaD
Memantine—GRIN2A—Reelin signaling pathway—ITGB1—dilated cardiomyopathy	0.00453	0.0111	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.0041	0.0101	CbGpPWpGaD
Memantine—GRIN2B—Reelin signaling pathway—ITGB1—dilated cardiomyopathy	0.00385	0.00944	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00379	0.00929	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.00358	0.00878	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.00349	0.00856	CbGpPWpGaD
Memantine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00336	0.00567	CcSEcCtD
Memantine—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00335	0.00566	CcSEcCtD
Memantine—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00334	0.00564	CcSEcCtD
Memantine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00333	0.00562	CcSEcCtD
Memantine—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00328	0.00554	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00324	0.00796	CbGpPWpGaD
Memantine—Otitis media—Lisinopril—dilated cardiomyopathy	0.00317	0.00536	CcSEcCtD
Memantine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00316	0.00533	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.00315	0.00774	CbGpPWpGaD
Memantine—HTR3A—Ion channel transport—RYR2—dilated cardiomyopathy	0.00315	0.00772	CbGpPWpGaD
Memantine—HTR3A—Ion channel transport—PLN—dilated cardiomyopathy	0.00306	0.00751	CbGpPWpGaD
Memantine—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00298	0.00503	CcSEcCtD
Memantine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00298	0.00503	CcSEcCtD
Memantine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00298	0.00503	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00293	0.00718	CbGpPWpGaD
Memantine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00287	0.00485	CcSEcCtD
Memantine—Mental disability—Furosemide—dilated cardiomyopathy	0.00286	0.00482	CcSEcCtD
Memantine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00279	0.00471	CcSEcCtD
Memantine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00276	0.00466	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.00275	0.00675	CbGpPWpGaD
Memantine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00275	0.00464	CcSEcCtD
Memantine—Polyuria—Furosemide—dilated cardiomyopathy	0.00272	0.0046	CcSEcCtD
Memantine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00272	0.00459	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0027	0.00662	CbGpPWpGaD
Memantine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00269	0.00453	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.00268	0.00658	CbGpPWpGaD
Memantine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00267	0.00451	CcSEcCtD
Memantine—Deafness—Furosemide—dilated cardiomyopathy	0.00267	0.00451	CcSEcCtD
Memantine—Gout—Lisinopril—dilated cardiomyopathy	0.00265	0.00447	CcSEcCtD
Memantine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00263	0.00444	CcSEcCtD
Memantine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.0026	0.00438	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00255	0.00626	CbGpPWpGaD
Memantine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.0025	0.00422	CcSEcCtD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00249	0.0061	CbGpPWpGaD
Memantine—Purpura—Furosemide—dilated cardiomyopathy	0.00248	0.00419	CcSEcCtD
Memantine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00247	0.00417	CcSEcCtD
Memantine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00246	0.00414	CcSEcCtD
Memantine—Lethargy—Furosemide—dilated cardiomyopathy	0.00244	0.00412	CcSEcCtD
Memantine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00243	0.0041	CcSEcCtD
Memantine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00241	0.00407	CcSEcCtD
Memantine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.0024	0.00405	CcSEcCtD
Memantine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.0024	0.00405	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—PSEN2—dilated cardiomyopathy	0.00239	0.00588	CbGpPWpGaD
Memantine—Malaise—Spironolactone—dilated cardiomyopathy	0.00239	0.00403	CcSEcCtD
Memantine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00239	0.00403	CcSEcCtD
Memantine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00237	0.004	CcSEcCtD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—RAF1—dilated cardiomyopathy	0.00235	0.00575	CbGpPWpGaD
Memantine—GRIN1—EPHB-mediated forward signaling—RAC1—dilated cardiomyopathy	0.00234	0.00574	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—PSEN2—dilated cardiomyopathy	0.00233	0.00573	CbGpPWpGaD
Memantine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00233	0.00394	CcSEcCtD
Memantine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00232	0.00392	CcSEcCtD
Memantine—Irritability—Furosemide—dilated cardiomyopathy	0.00228	0.00385	CcSEcCtD
Memantine—GRIN2B—EPHB-mediated forward signaling—RAC1—dilated cardiomyopathy	0.00228	0.00559	CbGpPWpGaD
Memantine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00227	0.00384	CcSEcCtD
Memantine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00224	0.00378	CcSEcCtD
Memantine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00223	0.00377	CcSEcCtD
Memantine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00223	0.00376	CcSEcCtD
Memantine—Dehydration—Furosemide—dilated cardiomyopathy	0.00222	0.00375	CcSEcCtD
Memantine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.0022	0.00371	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0022	0.0054	CbGpPWpGaD
Memantine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00218	0.00369	CcSEcCtD
Memantine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00218	0.00368	CcSEcCtD
Memantine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00218	0.00367	CcSEcCtD
Memantine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00217	0.00366	CcSEcCtD
Memantine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00211	0.00357	CcSEcCtD
Memantine—GRIN1—Axon guidance—SCN5A—dilated cardiomyopathy	0.00211	0.00518	CbGpPWpGaD
Memantine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00211	0.00356	CcSEcCtD
Memantine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00207	0.0035	CcSEcCtD
Memantine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00206	0.00348	CcSEcCtD
Memantine—GRIN2B—Axon guidance—SCN5A—dilated cardiomyopathy	0.00206	0.00505	CbGpPWpGaD
Memantine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00205	0.00346	CcSEcCtD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—RAF1—dilated cardiomyopathy	0.00205	0.00502	CbGpPWpGaD
Memantine—DRD2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00203	0.00498	CbGpPWpGaD
Memantine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00203	0.00342	CcSEcCtD
Memantine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00202	0.00342	CcSEcCtD
Memantine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.002	0.00337	CcSEcCtD
Memantine—Eczema—Lisinopril—dilated cardiomyopathy	0.002	0.00337	CcSEcCtD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.002	0.0049	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—RAF1—dilated cardiomyopathy	0.00199	0.00489	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00199	0.00488	CbGpPWpGaD
Memantine—Injury—Lisinopril—dilated cardiomyopathy	0.00195	0.00329	CcSEcCtD
Memantine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00194	0.00328	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00194	0.00475	CbGpPWpGaD
Memantine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00193	0.00326	CcSEcCtD
Memantine—GRIN2A—Post NMDA receptor activation events—RAF1—dilated cardiomyopathy	0.00193	0.00474	CbGpPWpGaD
Memantine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00192	0.00324	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00192	0.00471	CbGpPWpGaD
Memantine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00191	0.00322	CcSEcCtD
Memantine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00189	0.00319	CcSEcCtD
Memantine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00188	0.00318	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00187	0.00459	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00187	0.00459	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00186	0.00315	CcSEcCtD
Memantine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00186	0.00315	CcSEcCtD
Memantine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00185	0.00312	CcSEcCtD
Memantine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00184	0.0031	CcSEcCtD
Memantine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00183	0.00309	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00183	0.00308	CcSEcCtD
Memantine—Renal failure—Furosemide—dilated cardiomyopathy	0.00181	0.00306	CcSEcCtD
Memantine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.0018	0.00304	CcSEcCtD
Memantine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00179	0.00303	CcSEcCtD
Memantine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00179	0.00303	CcSEcCtD
Memantine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00179	0.00303	CcSEcCtD
Memantine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00178	0.003	CcSEcCtD
Memantine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00178	0.003	CcSEcCtD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00178	0.00436	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00177	0.00435	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—ABCC9—dilated cardiomyopathy	0.00176	0.00431	CbGpPWpGaD
Memantine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00174	0.00294	CcSEcCtD
Memantine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00172	0.0029	CcSEcCtD
Memantine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00172	0.0029	CcSEcCtD
Memantine—Irritability—Lisinopril—dilated cardiomyopathy	0.00171	0.00289	CcSEcCtD
Memantine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00171	0.00288	CcSEcCtD
Memantine—DRD2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00171	0.00419	CbGpPWpGaD
Memantine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00171	0.00288	CcSEcCtD
Memantine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00169	0.00285	CcSEcCtD
Memantine—GRIN2A—Neuronal System—ACTN2—dilated cardiomyopathy	0.00168	0.00413	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—RAF1—dilated cardiomyopathy	0.00168	0.00413	CbGpPWpGaD
Memantine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00168	0.00284	CcSEcCtD
Memantine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00167	0.00282	CcSEcCtD
Memantine—DRD2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00164	0.00403	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—RAF1—dilated cardiomyopathy	0.00164	0.00403	CbGpPWpGaD
Memantine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00164	0.00277	CcSEcCtD
Memantine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00163	0.00276	CcSEcCtD
Memantine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00162	0.00274	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—FAS—dilated cardiomyopathy	0.00162	0.00397	CbGpPWpGaD
Memantine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.0016	0.00271	CcSEcCtD
Memantine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00159	0.00269	CcSEcCtD
Memantine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00159	0.00269	CcSEcCtD
Memantine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00159	0.00268	CcSEcCtD
Memantine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00156	0.00264	CcSEcCtD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00155	0.0038	CbGpPWpGaD
Memantine—Asthma—Lisinopril—dilated cardiomyopathy	0.00155	0.00262	CcSEcCtD
Memantine—Influenza—Lisinopril—dilated cardiomyopathy	0.00155	0.00262	CcSEcCtD
Memantine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00155	0.00261	CcSEcCtD
Memantine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00154	0.0026	CcSEcCtD
Memantine—GRIN1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00153	0.00376	CbGpPWpGaD
Memantine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00153	0.00258	CcSEcCtD
Memantine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00153	0.00257	CcSEcCtD
Memantine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00152	0.00257	CcSEcCtD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00151	0.00371	CbGpPWpGaD
Memantine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00151	0.00255	CcSEcCtD
Memantine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00151	0.00255	CcSEcCtD
Memantine—GRIN1—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00151	0.0037	CbGpPWpGaD
Memantine—Angiopathy—Furosemide—dilated cardiomyopathy	0.0015	0.00253	CcSEcCtD
Memantine—GRIN2B—Neuronal System—ABCC9—dilated cardiomyopathy	0.00149	0.00367	CbGpPWpGaD
Memantine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00149	0.00252	CcSEcCtD
Memantine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00149	0.00252	CcSEcCtD
Memantine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00148	0.00249	CcSEcCtD
Memantine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00148	0.00249	CcSEcCtD
Memantine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00147	0.00249	CcSEcCtD
Memantine—GRIN1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00147	0.00361	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00147	0.0036	CbGpPWpGaD
Memantine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00145	0.00245	CcSEcCtD
Memantine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00145	0.00245	CcSEcCtD
Memantine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00144	0.00243	CcSEcCtD
Memantine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00144	0.00243	CcSEcCtD
Memantine—GRIN2B—Neuronal System—ACTN2—dilated cardiomyopathy	0.00143	0.00352	CbGpPWpGaD
Memantine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00143	0.00241	CcSEcCtD
Memantine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00143	0.00241	CcSEcCtD
Memantine—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00143	0.0035	CbGpPWpGaD
Memantine—Flatulence—Furosemide—dilated cardiomyopathy	0.00142	0.00239	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—FAS—dilated cardiomyopathy	0.00141	0.00346	CbGpPWpGaD
Memantine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00141	0.00238	CcSEcCtD
Memantine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00141	0.00238	CcSEcCtD
Memantine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.0014	0.00237	CcSEcCtD
Memantine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.0014	0.00236	CcSEcCtD
Memantine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00139	0.00235	CcSEcCtD
Memantine—DRD2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00138	0.00339	CbGpPWpGaD
Memantine—Depression—Lisinopril—dilated cardiomyopathy	0.00138	0.00233	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—FAS—dilated cardiomyopathy	0.00138	0.00338	CbGpPWpGaD
Memantine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00137	0.00232	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00137	0.00231	CcSEcCtD
Memantine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00136	0.0023	CcSEcCtD
Memantine—Rash—Spironolactone—dilated cardiomyopathy	0.00136	0.0023	CcSEcCtD
Memantine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00136	0.0023	CcSEcCtD
Memantine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00136	0.00229	CcSEcCtD
Memantine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00136	0.00229	CcSEcCtD
Memantine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00136	0.00229	CcSEcCtD
Memantine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00136	0.00229	CcSEcCtD
Memantine—Headache—Spironolactone—dilated cardiomyopathy	0.00135	0.00228	CcSEcCtD
Memantine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00134	0.00227	CcSEcCtD
Memantine—Anaemia—Furosemide—dilated cardiomyopathy	0.00133	0.00225	CcSEcCtD
Memantine—Agitation—Furosemide—dilated cardiomyopathy	0.00132	0.00223	CcSEcCtD
Memantine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00132	0.00222	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00132	0.00323	CbGpPWpGaD
Memantine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00131	0.00221	CcSEcCtD
Memantine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0013	0.0022	CcSEcCtD
Memantine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.0013	0.00219	CcSEcCtD
Memantine—Vertigo—Furosemide—dilated cardiomyopathy	0.00129	0.00218	CcSEcCtD
Memantine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00129	0.00218	CcSEcCtD
Memantine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00129	0.00218	CcSEcCtD
Memantine—Nausea—Spironolactone—dilated cardiomyopathy	0.00128	0.00217	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00127	0.00311	CbGpPWpGaD
Memantine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00126	0.00213	CcSEcCtD
Memantine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00124	0.0021	CcSEcCtD
Memantine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00124	0.00209	CcSEcCtD
Memantine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00123	0.00208	CcSEcCtD
Memantine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00123	0.00208	CcSEcCtD
Memantine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00123	0.00207	CcSEcCtD
Memantine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00122	0.00206	CcSEcCtD
Memantine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00122	0.00205	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.0012	0.00295	CbGpPWpGaD
Memantine—Dry mouth—Furosemide—dilated cardiomyopathy	0.0012	0.00202	CcSEcCtD
Memantine—Confusional state—Furosemide—dilated cardiomyopathy	0.00118	0.002	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.00117	0.00288	CbGpPWpGaD
Memantine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00117	0.00198	CcSEcCtD
Memantine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00116	0.00195	CcSEcCtD
Memantine—Shock—Furosemide—dilated cardiomyopathy	0.00116	0.00195	CcSEcCtD
Memantine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00115	0.00194	CcSEcCtD
Memantine—Flushing—Lisinopril—dilated cardiomyopathy	0.00115	0.00194	CcSEcCtD
Memantine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00115	0.00194	CcSEcCtD
Memantine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00114	0.00193	CcSEcCtD
Memantine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00114	0.00192	CcSEcCtD
Memantine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00113	0.0019	CcSEcCtD
Memantine—Anorexia—Furosemide—dilated cardiomyopathy	0.00112	0.00189	CcSEcCtD
Memantine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00112	0.00189	CcSEcCtD
Memantine—Chills—Lisinopril—dilated cardiomyopathy	0.00111	0.00188	CcSEcCtD
Memantine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00111	0.00187	CcSEcCtD
Memantine—Hypotension—Furosemide—dilated cardiomyopathy	0.0011	0.00185	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.0011	0.00269	CbGpPWpGaD
Memantine—Alopecia—Lisinopril—dilated cardiomyopathy	0.0011	0.00185	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0011	0.00269	CbGpPWpGaD
Memantine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00109	0.00184	CcSEcCtD
Memantine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00108	0.00182	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00107	0.00261	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00107	0.00261	CbGpPWpGaD
Memantine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00106	0.0018	CcSEcCtD
Memantine—Tension—Lisinopril—dilated cardiomyopathy	0.00106	0.00179	CcSEcCtD
Memantine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00106	0.00179	CcSEcCtD
Memantine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00106	0.00178	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00105	0.00259	CbGpPWpGaD
Memantine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00105	0.00177	CcSEcCtD
Memantine—Back pain—Lisinopril—dilated cardiomyopathy	0.00104	0.00176	CcSEcCtD
Memantine—Somnolence—Furosemide—dilated cardiomyopathy	0.00104	0.00176	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00104	0.00254	CbGpPWpGaD
Memantine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00102	0.00172	CcSEcCtD
Memantine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00102	0.00172	CcSEcCtD
Memantine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00101	0.00171	CcSEcCtD
Memantine—Fatigue—Furosemide—dilated cardiomyopathy	0.00101	0.00171	CcSEcCtD
Memantine—Tremor—Lisinopril—dilated cardiomyopathy	0.00101	0.00171	CcSEcCtD
Memantine—Pain—Furosemide—dilated cardiomyopathy	0.001	0.0017	CcSEcCtD
Memantine—Constipation—Furosemide—dilated cardiomyopathy	0.001	0.0017	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.001	0.00246	CbGpPWpGaD
Memantine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.001	0.00169	CcSEcCtD
Memantine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000998	0.00169	CcSEcCtD
Memantine—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000997	0.00245	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000991	0.00243	CbGpPWpGaD
Memantine—Malaise—Lisinopril—dilated cardiomyopathy	0.000974	0.00164	CcSEcCtD
Memantine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000971	0.00164	CcSEcCtD
Memantine—Syncope—Lisinopril—dilated cardiomyopathy	0.000969	0.00164	CcSEcCtD
Memantine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000968	0.00163	CcSEcCtD
Memantine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000967	0.00163	CcSEcCtD
Memantine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000961	0.00162	CcSEcCtD
Memantine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000955	0.00161	CcSEcCtD
Memantine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000949	0.0016	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000947	0.00232	CbGpPWpGaD
Memantine—Cough—Lisinopril—dilated cardiomyopathy	0.000943	0.00159	CcSEcCtD
Memantine—Urticaria—Furosemide—dilated cardiomyopathy	0.000933	0.00158	CcSEcCtD
Memantine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000929	0.00157	CcSEcCtD
Memantine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000929	0.00157	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000924	0.00227	CbGpPWpGaD
Memantine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00092	0.00155	CcSEcCtD
Memantine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00092	0.00155	CcSEcCtD
Memantine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00092	0.00155	CcSEcCtD
Memantine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000917	0.00155	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000914	0.00224	CbGpPWpGaD
Memantine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000909	0.00153	CcSEcCtD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000907	0.00223	CbGpPWpGaD
Memantine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000899	0.00152	CcSEcCtD
Memantine—GRIN1—Axon guidance—PSEN2—dilated cardiomyopathy	0.00089	0.00218	CbGpPWpGaD
Memantine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000889	0.0015	CcSEcCtD
Memantine—Oedema—Lisinopril—dilated cardiomyopathy	0.000882	0.00149	CcSEcCtD
Memantine—Infection—Lisinopril—dilated cardiomyopathy	0.000876	0.00148	CcSEcCtD
Memantine—Shock—Lisinopril—dilated cardiomyopathy	0.000867	0.00146	CcSEcCtD
Memantine—GRIN2B—Axon guidance—PSEN2—dilated cardiomyopathy	0.000867	0.00213	CbGpPWpGaD
Memantine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000866	0.00146	CcSEcCtD
Memantine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000863	0.00146	CcSEcCtD
Memantine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00086	0.00145	CcSEcCtD
Memantine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000856	0.00145	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000856	0.0021	CbGpPWpGaD
Memantine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000852	0.00144	CcSEcCtD
Memantine—Asthenia—Furosemide—dilated cardiomyopathy	0.000843	0.00142	CcSEcCtD
Memantine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00084	0.00142	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000834	0.00205	CbGpPWpGaD
Memantine—Pruritus—Furosemide—dilated cardiomyopathy	0.000831	0.0014	CcSEcCtD
Memantine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000824	0.00139	CcSEcCtD
Memantine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000804	0.00136	CcSEcCtD
Memantine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000803	0.00136	CcSEcCtD
Memantine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000797	0.00135	CcSEcCtD
Memantine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000797	0.00196	CbGpPWpGaD
Memantine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000792	0.00134	CcSEcCtD
Memantine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000786	0.00133	CcSEcCtD
Memantine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000784	0.00132	CcSEcCtD
Memantine—Dizziness—Furosemide—dilated cardiomyopathy	0.000777	0.00131	CcSEcCtD
Memantine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000776	0.00131	CcSEcCtD
Memantine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000766	0.00129	CcSEcCtD
Memantine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000764	0.00187	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000761	0.00128	CcSEcCtD
Memantine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00076	0.00128	CcSEcCtD
Memantine—Pain—Lisinopril—dilated cardiomyopathy	0.000754	0.00127	CcSEcCtD
Memantine—Constipation—Lisinopril—dilated cardiomyopathy	0.000754	0.00127	CcSEcCtD
Memantine—Vomiting—Furosemide—dilated cardiomyopathy	0.000747	0.00126	CcSEcCtD
Memantine—Rash—Furosemide—dilated cardiomyopathy	0.000741	0.00125	CcSEcCtD
Memantine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00074	0.00125	CcSEcCtD
Memantine—Headache—Furosemide—dilated cardiomyopathy	0.000736	0.00124	CcSEcCtD
Memantine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000727	0.00123	CcSEcCtD
Memantine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000721	0.00122	CcSEcCtD
Memantine—Urticaria—Lisinopril—dilated cardiomyopathy	0.0007	0.00118	CcSEcCtD
Memantine—Nausea—Furosemide—dilated cardiomyopathy	0.000698	0.00118	CcSEcCtD
Memantine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000697	0.00118	CcSEcCtD
Memantine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000697	0.00118	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000687	0.00169	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000666	0.00163	CbGpPWpGaD
Memantine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00065	0.0011	CcSEcCtD
Memantine—GRIN1—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000635	0.00156	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000633	0.00155	CbGpPWpGaD
Memantine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000633	0.00107	CcSEcCtD
Memantine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000624	0.00105	CcSEcCtD
Memantine—HTR3A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000621	0.00152	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000619	0.00152	CbGpPWpGaD
Memantine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000603	0.00102	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000599	0.00147	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000584	0.00143	CbGpPWpGaD
Memantine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000583	0.000984	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000581	0.00142	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000568	0.00139	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000566	0.00139	CbGpPWpGaD
Memantine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000561	0.000946	CcSEcCtD
Memantine—GRIN1—Axon guidance—ITGB1—dilated cardiomyopathy	0.000557	0.00137	CbGpPWpGaD
Memantine—Rash—Lisinopril—dilated cardiomyopathy	0.000556	0.000938	CcSEcCtD
Memantine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000555	0.000937	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000553	0.00136	CbGpPWpGaD
Memantine—Headache—Lisinopril—dilated cardiomyopathy	0.000552	0.000932	CcSEcCtD
Memantine—GRIN2B—Axon guidance—ITGB1—dilated cardiomyopathy	0.000543	0.00133	CbGpPWpGaD
Memantine—Nausea—Lisinopril—dilated cardiomyopathy	0.000524	0.000884	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0005	0.00123	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000474	0.00116	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000469	0.00115	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000469	0.00115	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000461	0.00113	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000461	0.00113	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000456	0.00112	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—RAC1—dilated cardiomyopathy	0.000447	0.0011	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000436	0.00107	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—RAC1—dilated cardiomyopathy	0.000436	0.00107	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000436	0.00107	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000435	0.00107	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000435	0.00107	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000428	0.00105	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000425	0.00104	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000418	0.00103	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000404	0.000992	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000397	0.000975	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000392	0.000961	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000391	0.00096	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000387	0.00095	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—RAF1—dilated cardiomyopathy	0.000383	0.000941	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000373	0.000914	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000373	0.000914	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000368	0.000903	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000348	0.000853	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000346	0.00085	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CD36—dilated cardiomyopathy	0.000339	0.000831	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000336	0.000823	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000334	0.000821	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—RAF1—dilated cardiomyopathy	0.000334	0.000821	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CD36—dilated cardiomyopathy	0.00033	0.00081	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—RAF1—dilated cardiomyopathy	0.000326	0.0008	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—RAC1—dilated cardiomyopathy	0.000319	0.000783	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000317	0.000779	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000311	0.000764	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—RAC1—dilated cardiomyopathy	0.000311	0.000764	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000307	0.000753	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—RAF1—dilated cardiomyopathy	0.000297	0.000728	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	0.000293	0.000719	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—RAF1—dilated cardiomyopathy	0.000289	0.00071	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000287	0.000703	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000286	0.000702	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000284	0.000696	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000284	0.000696	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000272	0.000667	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.000269	0.00066	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	0.000265	0.00065	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000264	0.000647	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000255	0.000627	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000254	0.000622	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000243	0.000597	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000231	0.000566	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000227	0.000557	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000218	0.000535	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000217	0.000532	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000216	0.00053	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—RAF1—dilated cardiomyopathy	0.000212	0.00052	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000207	0.000508	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—RAF1—dilated cardiomyopathy	0.000206	0.000506	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—dilated cardiomyopathy	0.000203	0.000499	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000202	0.000495	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—dilated cardiomyopathy	0.000198	0.000487	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000196	0.000481	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000174	0.000428	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	0.000174	0.000427	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000164	0.000402	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00016	0.000393	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00016	0.000393	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000154	0.000377	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000149	0.000366	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000148	0.000364	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000146	0.000357	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000146	0.000357	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—dilated cardiomyopathy	0.000145	0.000356	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000144	0.000354	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—dilated cardiomyopathy	0.000142	0.000347	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—dilated cardiomyopathy	0.000138	0.000339	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000135	0.000332	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—dilated cardiomyopathy	0.000135	0.000331	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000131	0.000322	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000123	0.000303	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000117	0.000287	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000112	0.000275	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000106	0.000261	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.69e-05	0.000238	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.35e-05	0.000229	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.08e-05	0.000223	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.04e-05	0.000222	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.8e-05	0.000216	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.68e-05	0.000213	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.6e-05	0.000211	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.6e-05	0.000211	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.25e-05	0.000202	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	8e-05	0.000196	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.93e-05	0.000195	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	7.88e-05	0.000193	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.75e-05	0.00019	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	7.19e-05	0.000177	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	7.01e-05	0.000172	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.61e-05	0.000162	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	6.6e-05	0.000162	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	6.43e-05	0.000158	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	6.31e-05	0.000155	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.28e-05	0.000154	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	5.79e-05	0.000142	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.47e-05	0.000134	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.39e-05	0.000132	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	5.33e-05	0.000131	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	5.19e-05	0.000127	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.87e-05	0.00012	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	4.67e-05	0.000115	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	4.65e-05	0.000114	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	4.03e-05	9.88e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.92e-05	9.62e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.75e-05	9.2e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.53e-05	8.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.23e-05	7.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.22e-05	5.44e-05	CbGpPWpGaD
